AstraZeneca’s COVID-19 vaccine candidate: UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study
by Press Release from Outbreak News Today on (#59PNX)
University Hospitals (UH) and Case Western Reserve University (CWRU) announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca (LSE/STO/NYSE: AZN). The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), [...]
The post AstraZeneca's COVID-19 vaccine candidate: UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study appeared first on Outbreak News Today.